» Articles » PMID: 32755385

An Indisputable Role of NHE8 in Mucosal Protection

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The loss of the intestinal Na/H exchanger isoform 8 (NHE8) results in an ulcerative colitis-like condition with reduction of mucin production and dysbiosis, indicating that NHE8 plays an important role in intestinal mucosal protection. The aim of this study was to investigate the potential rebalance of the altered microbiota community of NHE8-deficient mice via fecal microbiota transplantation (FMT) and feeding probiotic VSL#3. We also aimed to stimulate mucin production by sodium butyrate administration via enema. Data from 16S rRNA sequencing showed that loss of NHE8 contributes to colonic microbial dysbiosis with reduction of butyrate-producing bacteria. FMT increased bacterial adhesion in the colon in NHE8 knockout (NHE8KO) mice. Periodic-acid Schiff reagent (PAS) stain and quantitative PCR showed no changes in mucin production during FMT. In mice treated with the probiotic VSL#3, a reduction of and segmented filamentous bacteria (SFB) in NHE8KO mouse colon was detected and an increase in goblet cell theca was observed. In NHE8KO mice receiving sodium butyrate (NaB), 1 mM NaB stimulated Muc2 expression without changing goblet cell theca, but 10 mM NaB induced a significant reduction of goblet cell theca without altering Muc2 expression. Furthermore, 5 mM and 10 mM NaB-treated HT29-MTX cells displayed increased apoptosis, while 0.5 mM NaB stimulated Muc2 gene expression. These data showed that loss of NHE8 leads to dysbiosis with reduction of butyrate-producing bacteria and FMT and VSL#3 failed to rebalance the microbiota in NHE8KO mice. Therefore, FMT, VSL#3, and NaB are not able to restore mucin production in the absence of NHE8 in the intestine. Loss of Na/H exchanger isoform 8 (NHE8), a Slc9 family of exchanger that contributes to sodium uptake, cell volume regulation, and intracellular pH homeostasis, resulted in dysbiosis with reduction of butyrate-producing bacteria and decrease of Muc2 production in the intestine in mice. Introducing fecal microbiota transplantation (FMT) and VSL#3 in NHE8 knockout (NHE8KO) mice failed to rebalance the microbiota in these mice. Furthermore, administration of FMT, VSL#3, and sodium butyrate was unable to restore mucin production in the absence of NHE8 in the intestine.

Citing Articles

Compromised NHE8 Expression Is Responsible for Vitamin D-Deficiency Induced Intestinal Barrier Dysfunction.

Guo Y, Li Y, Tang Z, Geng C, Xie X, Song S Nutrients. 2023; 15(22).

PMID: 38004229 PMC: 10674576. DOI: 10.3390/nu15224834.


The Expression of NHE8 in Liver and Its Role in Carbon Tetrachloride-Induced Liver Injury.

Tong H, Bernardazzi C, Curiel L, Xu H, Ghishan F Gastro Hep Adv. 2023; 2(2):199-208.

PMID: 36936401 PMC: 10019310. DOI: 10.1016/j.gastha.2022.09.008.


Substituting meat for mycoprotein reduces genotoxicity and increases the abundance of beneficial microbes in the gut: Mycomeat, a randomised crossover control trial.

Farsi D, Gallegos J, Koutsidis G, Nelson A, Finnigan T, Cheung W Eur J Nutr. 2023; 62(3):1479-1492.

PMID: 36651990 PMC: 10030420. DOI: 10.1007/s00394-023-03088-x.


The Physiological Function and Potential Role of the Ubiquitous Na/H Exchanger Isoform 8 (NHE8): An Overview Data.

Bernardazzi C, Sheikh I, Xu H, Ghishan F Int J Mol Sci. 2022; 23(18).

PMID: 36142772 PMC: 9501935. DOI: 10.3390/ijms231810857.


The Role of Plasma Membrane Sodium/Hydrogen Exchangers in Gastrointestinal Functions: Proliferation and Differentiation, Fluid/Electrolyte Transport and Barrier Integrity.

Nikolovska K, Seidler U, Stock C Front Physiol. 2022; 13:899286.

PMID: 35665228 PMC: 9159811. DOI: 10.3389/fphys.2022.899286.


References
1.
Xu H, Li J, Chen H, Wang C, Ghishan F . NHE8 plays important roles in gastric mucosal protection. Am J Physiol Gastrointest Liver Physiol. 2012; 304(3):G257-61. PMC: 3566513. DOI: 10.1152/ajpgi.00433.2012. View

2.
Wang S, Xu M, Wang W, Cao X, Piao M, Khan S . Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One. 2016; 11(8):e0161174. PMC: 4986962. DOI: 10.1371/journal.pone.0161174. View

3.
Chapman T, Plosker G, Figgitt D . VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs. 2006; 66(10):1371-87. DOI: 10.2165/00003495-200666100-00006. View

4.
Chang C, Lee H, Li L, Chiang Chiau J, Wang T, Chuang W . Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer. Int J Mol Sci. 2020; 21(2). PMC: 7013718. DOI: 10.3390/ijms21020386. View

5.
Caballero-Franco C, Keller K, De Simone C, Chadee K . The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2006; 292(1):G315-22. DOI: 10.1152/ajpgi.00265.2006. View